SS
CTSO icon

SBI Securities’s Cytosorbents Corp CTSO Stock Holding History

SBI Securities’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
1
– – ﹤0.01% 4099
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 3978
2025
Q4 		– Sell
-1
Closed -$1 – 4075
2025
Q3 		$1 Sell
1
-99
-99% -$98 ﹤0.01% 4167
2025
Q2 		$128 Hold
100
– – ﹤0.01% 3455
2025
Q1 		$100 Hold
100
– – ﹤0.01% 3440
2024
Q4 		$91 Buy
+100
New +$98 ﹤0.01% 3485

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

SBI Securities's CTSO Position: Q2 2026 in Review

SBI Securities held its Cytosorbents Corp (CTSO) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4099.

SBI Securities first reported a position in CTSO in Q4 2024 and has held it in 6 quarters since. The position peaked at $128 in Q2 2025. 42 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • SBI Securities held 1 share of Cytosorbents Corp worth $0 as of Q2 2026.
  • SBI Securities left its Cytosorbents Corp share count unchanged in Q2 2026.
  • Cytosorbents Corp made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #4099 holding.
  • SBI Securities first reported a position in Cytosorbents Corp in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Cytosorbents Corp position peaked at $128 in Q2 2025.
  • 42 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.